Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Chamaerops humilis genome sequencing

PROVIDER: PRJNA1081886 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR29081396.fastq.gz	Fastqsanger.gz
	SRR29081397_1.fastq.gz	Fastqsanger.gz
	SRR29081397_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Chamaerops humilis cultivar:ZC9-3-CK1

Project description:Chamaerops humilis genome sequencing

| PRJNA1066107 | ENA

Chamaerops humilis

Project description:Chamaerops humilis overview

| PRJNA1166363 | ENA

Project description:Chloroplast Chamaerops humilis

| PRJNA1112609 | ENA

Chamaerops humilis

Project description:Chamaerops humilis alternate haplotype genome sequencing 1

| PRJNA1066108 | ENA

Chamaerops humilis

Project description:Chamaerops humilis alternate haplotype genome sequencing 2

| PRJNA1066109 | ENA

Pseudopodoces humilis Transcriptome data used for gene annotation

Project description:To optimize the genome annotation, two tissue RNA libraries (i.e. liver and muscle) were constructed using the Illumina mRNA-Seq Prep Kit This study is a part of the Pseudopodoces humilis WGS project (BioProject ID: PRJNA179234) and was used for gene annotation improvement.

2013-11-29 | GSE44779 | GEO

Chamaerops humilis

Project description:ChAMPION - Chamaerops humilis reference genome sequencing for Active conservation of an endemic Mediterranean Palm Including analyses Of biotic interactions Network

| PRJNA1247256 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Pseudopodoces humilis

Project description:Pseudopodoces humilis Genome sequencing

| PRJNA179234 | ENA

Pseudopodoces humilis

Project description:Pseudopodoces humilis Genome sequencing

| PRJNA293020 | ENA